FreeRx
Artemether + Lumefantrine Tablets
Artemether 20 mg + Lumefantrine 120 mg
Target markets: Africa, SE Asia
FormulationsFreely Exportable
Dolutegravir Tablets
Dolutegravir Sodium
WHO-GMP Partner-Manufactured
Target: Africa, SE Asia
Regulatory-Aware Support
Reliable Supply Chain
Product Overview
An integrase inhibitor used in first-line HIV therapy, including as part of the TLD fixed-dose combination. Supplied to donor-funded and institutional ARV procurement programmes through WHO-GMP certified manufacturing partners.
Key Points
- Core component of WHO-recommended first-line ARV regimens
- Also available as TLD fixed-dose combination
- Donor-funded and tender-driven procurement supported
Quick Specifications
| Generic Name | Dolutegravir Sodium |
|---|---|
| Dosage Form | Tablet |
| Strength | 50 mg |
| HS Code | 3004.90 |
| Packaging | Bottles (30s, 90s), institutional bulk packs |
| MOQ | MOQ on request — tender quantities supported |
| Shelf Life | 24 months, batch-dependent |
| Storage | Store below 30°C |
Regulatory Information
Schedule H — Prescription Only
Schedule H — B2B and institutional/tender supply only. WHO Prequalification status confirmed per manufacturing partner at quotation stage.
View Antiretrovirals (HIV) class detailsRequirements vary by destination. Verify current requirements with the relevant authority before shipment. See our Compliance page.
Need documentation first?
Our team can share a product brochure and manufacturing-partner regulatory summary on request — just mention it in your enquiry.